Albrecht J, Czuczwar S, Zielinska M, Miziak B
Neurochem Res. 2025; 50(2):84.
PMID: 39843842
DOI: 10.1007/s11064-024-04329-z.
Markussen K, Corti M, Byrne B, Vander Kooi C, Sun R, Gentry M
J Neurochem. 2023; 168(5):728-743.
PMID: 37554056
PMC: 10901277.
DOI: 10.1111/jnc.15926.
Andersen J, Schousboe A
Neurochem Res. 2022; 48(4):1100-1128.
PMID: 36322369
DOI: 10.1007/s11064-022-03771-1.
Farina M, Sandhu M, Parent M, Sanganahalli B, Derbin M, Dhaher R
Epilepsia. 2021; 62(11):2858-2870.
PMID: 34536233
PMC: 9006438.
DOI: 10.1111/epi.17072.
Dhaher R, Gruenbaum S, Sandhu M, Ottestad-Hansen S, Tu N, Wang Y
Neurology. 2021; 96(18):e2261-e2271.
PMID: 33722994
PMC: 8166437.
DOI: 10.1212/WNL.0000000000011846.
Metabolomic and Imaging Mass Spectrometric Assays of Labile Brain Metabolites: Critical Importance of Brain Harvest Procedures.
Dienel G
Neurochem Res. 2020; 45(11):2586-2606.
PMID: 32949339
DOI: 10.1007/s11064-020-03124-w.
Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients.
Dienel G, Rothman D, Nordstrom C
J Cereb Blood Flow Metab. 2016; 36(11):1844-1864.
PMID: 27604313
PMC: 5094313.
DOI: 10.1177/0271678X16666552.
Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.
DiNuzzo M, Mangia S, Maraviglia B, Giove F
Epilepsy Res. 2014; 108(6):995-1012.
PMID: 24818957
PMC: 4838019.
DOI: 10.1016/j.eplepsyres.2014.04.001.
Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?.
DiNuzzo M, Mangia S, Maraviglia B, Giove F
Metab Brain Dis. 2014; 30(1):307-16.
PMID: 24643875
PMC: 4169361.
DOI: 10.1007/s11011-014-9524-5.
The effect of methionine on the uptake, distribution, and binding of the convulsant methionine sulfoximine in the rat.
Schatz R, Harris R, Sellinger O
Neurochem Res. 2013; 1(1):53-63.
PMID: 24271244
DOI: 10.1007/BF00965631.
Regulation of astrocyte glutamine synthetase in epilepsy.
Eid T, Tu N, Lee T, Lai J
Neurochem Int. 2013; 63(7):670-81.
PMID: 23791709
PMC: 3825815.
DOI: 10.1016/j.neuint.2013.06.008.
Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Cooper A
Metab Brain Dis. 2012; 28(2):119-25.
PMID: 23065027
PMC: 3566340.
DOI: 10.1007/s11011-012-9338-2.
Astrocytic regulation of glutamate homeostasis in epilepsy.
Coulter D, Eid T
Glia. 2012; 60(8):1215-26.
PMID: 22592998
PMC: 3375386.
DOI: 10.1002/glia.22341.
Roles of glutamine synthetase inhibition in epilepsy.
Eid T, Behar K, Dhaher R, Bumanglag A, Lee T
Neurochem Res. 2012; 37(11):2339-50.
PMID: 22488332
PMC: 3731630.
DOI: 10.1007/s11064-012-0766-5.
Mitochondria, oxidative stress, and temporal lobe epilepsy.
Waldbaum S, Patel M
Epilepsy Res. 2009; 88(1):23-45.
PMID: 19850449
PMC: 3236664.
DOI: 10.1016/j.eplepsyres.2009.09.020.
The development of recurrent seizures after continuous intrahippocampal infusion of methionine sulfoximine in rats: a video-intracranial electroencephalographic study.
Wang Y, Zaveri H, Lee T, Eid T
Exp Neurol. 2009; 220(2):293-302.
PMID: 19747915
PMC: 2989153.
DOI: 10.1016/j.expneurol.2009.08.034.
Epilepsy, regulation of brain energy metabolism and neurotransmission.
Cloix J, Hevor T
Curr Med Chem. 2009; 16(7):841-53.
PMID: 19275597
PMC: 2765086.
DOI: 10.2174/092986709787549316.
Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats.
Eid T, Ghosh A, Wang Y, Beckstrom H, Zaveri H, Lee T
Brain. 2008; 131(Pt 8):2061-70.
PMID: 18669513
PMC: 2724901.
DOI: 10.1093/brain/awn133.
Astrocytes in the epileptic brain.
Wetherington J, Serrano G, Dingledine R
Neuron. 2008; 58(2):168-78.
PMID: 18439402
PMC: 4124883.
DOI: 10.1016/j.neuron.2008.04.002.
Regulation of fructose-1,6-bisphosphatase activity in primary cultured astrocytes.
Verge V, Hevor T
Neurochem Res. 1995; 20(9):1049-56.
PMID: 8570009
DOI: 10.1007/BF00995559.
